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The muscarinic M2 receptor is a prominent member of the GPCR family and strongly involved in heart
diseases. Recently published experimental work explored the cellular response to iperoxo-induced M2
receptor stimulation in Chinese hamster ovary (CHO) cells. To better understand these responses, we
modelled and analysed the muscarinic M2 receptor-dependent signalling pathway combined with rel-
evant secondary messenger molecules using mass action. In our literature-based joint signalling and
secondary messenger model, all binding and phosphorylation events are explicitly taken into account
in order to enable subsequent stoichiometric matrix analysis. We propose constraint ﬂux sampling (CFS)
as a method to characterize the expected shift of the steady state reaction ﬂux distribution due to the known
amount of cAMP production and PDE4 activation. CFS correctly predicts an experimentally observable
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inﬂuence on the cytoskeleton structure (marked by actin and tubulin) and in consequence a change of
the optical density of cells. In a second step, we use CFS to simulate the effect of knock-out experiments
within our biological system, and thus to rank the inﬂuence of individual molecules on the observed
change of the optical cell density. In particular, we conﬁrm the relevance of the protein RGS14, which is
supported by current literature. A combination of CFS with Elementary FluxMode analysis enabled us to
determine the possible underlying mechanism. Our analysis suggests that mathematical tools developed
for metabolic network analysis can also be applied to mixed secondary messenger and signalling models.
This could be very helpful to perform model checking with little effort and to generate hypotheses for
further research if parameters are not known.
Keywords: elementary ﬂux modes; signalling; ﬂux sampling; modelling.
1. Introduction
Themuscarinic acetylcholine receptor (M2 receptor) (encoded by theCHRM2 gene) belongs to the family
of G protein-coupled receptors (GPCR) and is among other locations expressed in cardiomyocytes where
it inﬂuences the heart beat rate (Brodde & Michel, 1999). It is related to negative dromotropic and
negative chronotropic events. Its malfunctioning has been associated with a number of diseases, such as
cardiomyopathies (Brodde & Michel, 1999). GPCRs represent one of the most important target classes
of proteins for drug discovery (Zheng, 2006). Hence, development of speciﬁc agonists and antagonists
for muscarinic receptors, including the M2 receptor, is still of high interest. Iperoxo is a highly afﬁne
and efﬁcacious muscarinic agonist (Schrage et al., 2013, 2014) that has recently served to elucidate the
crystal structure of the active state of the M2 receptor (Hu et al., 2010; Kruse et al., 2013). In traditional
pharmacology, the ligand-binding event, second messenger concentrations, ion channel function, as well
as tissue, organ or body responses are recorded. New label free, whole cell techniques nowadays are
used to dissect signalling of intact cells into different components (Schro¨der et al., 2011). In addition,
iperoxo and its derivatives turned out to be valuable tools for gaining deeper insight into structure-signal
relationships (Bock et al., 2014; Antony et al., 2009).
Recent experimental work explored the cellular response to iperoxo-induced M2 receptor stimulation
in Chinese hamster ovary (CHO) cells (Kruse et al., 2013; Schrage et al., 2013, 2015). The cellular
response was measured by dynamic mass redistribution (DMR), a technique to quantify the intracellular
mass movement via optical density (Schro¨der et al., 2011). Since the DMR response can be assumed to
be dependent on the M2 receptor-dependent signalling our aim was to model and study the corresponding
reaction system. The pathway consists of proteins as well as the secondary messenger cyclic adenosine
monophosphate (cAMP). The respective biochemical reactions are principally well known (Pierce et al.,
2002; Linderman, 2009; Sunahara & Taussig, 2002; Taylor et al., 2012), but to the best of our knowledge
no effort has been taken so far to derive a mathematical model, especially for CHO cells, which are very
important in pharmaceutical research and for the industrial production of recombinant protein therapeutics
(De Jesus & Wurm, 2011; Walsh, 2010).
In thiswork,wedeveloped amass action basedmathematical description of theM2 receptor-dependent
signalling network. Our developed model consists of 79 reactions, altogether involving 64 relevant pro-
teins and secondary messenger molecules described in literature. In our joint signalling and secondary
messenger model, all binding and (de-)phosphorylation events are explicitly taken into account in order
to enable subsequent stoichiometric matrix and ﬂux distribution analysis (Wiback et al., 2004). Although
this kind of analysis is usually only employed for metabolic networks, our explicit modelling of binding
and phosphorylation events enables the adaption of these techniques to a mixed signalling and secondary
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messenger system. The usefulness of applying stoichiometric matrix analysis techniques to signalling
pathways has e.g. been demonstrated by Behre & Schuster (2009), who adapted elementary ﬂux mode
(EFM) analysis to this situation. We here show, how the known ﬂux sampling technique (Smith, 1996)
can be extended to incorporate partially available experimental information (here: cAMP production,
phosphodiesterase 4 (PDE4) activation). We tested our combined modelling and data driven sampling
method by predicting key signalling mechanisms known from literature, but not explicitly encoded into
the model. Our proposed constraint ﬂux sampling (CFS) technique allows for qualitative predictions of
downstream stimulation effects on actin and tubulin levels, which here serve as markers for the mass
redistribution effect. These qualitative predictions are in agreement with the experimental observations,
which suggests CFS as a technique for model checking. This is further underlined by the possibility
to combine CFS and EFM analysis yielding a statistical ranking of EFMs according to their expected
biological relevance.
2. Methods
2.1 Biological Background and Network Reconstruction
GPCR-induced signalling is well-known in common literature (Pierce et al., 2002; Linderman, 2009;
Taylor et al., 2012; Sunahara & Taussig, 2002). Speciﬁcally the link to the cyclic AMP (cAMP – a
secondary messenger molecule)-induced signalling is in the focus of current pharmaceutical research
(Milligan & Kostenis, 2006; Hu et al., 2010). Figure 1 depicts a schematic representation of the whole
set of relevant molecules and their interplay, which are considered in our model. In particular, the process
of receptor-induced G protein (GP) activation is well studied, where the ligand-bound receptor changes
its physical structure and the inactive associated GP interacts with the receptor and dissociates into its
subunits (Pierce et al., 2002). Thereby the alpha-i/alpha-s and beta/gamma subunits are activated and are
able to interact independently with other proteins like adenylyl cyclase (AC) (Sunahara & Taussig, 2002;
Milligan & Kostenis, 2006). The GP subunit alpha-o has no signiﬁcant inﬂuence on AC but it has an
inﬂuence on the DMR (Milligan & Kostenis, 2006). AC is one of the most important proteins within the
GP-mediated pathway and responsible for the secondary messenger production. The large number of AC
and GP subtypes causes a highly complex sub-network with many cross-reactions (Milligan & Kostenis,
2006; Sunahara & Taussig, 2002). Also the receptor activation cycle itself is not trivial. This ﬁrst step in
the signalling cascade is highly interesting for pharmaceutical research and led to well-developed models
for receptor activation and inhibition (Woodroffe et al., 2009; Chen, 2003; Strange, 2009; Bornheimer
et al., 2004).
Besides this completely membrane bound sub-network the protein kinase A (PKA)-induced phos-
phorylation cascade, and the feedback loop causing cAMP degradation is well studied (Taylor et al.,
2012). Cyclic AMP binds to PKA and causes its activation. But an increase of PKA activity also leads
to an increase in phosphodiesterase (PDE) activity, which inactivates cAMP by degrading it to AMP
(Boswell-Smith et al., 2006). Through this mechanism the cell prevents a continuous overstimulation by
excessive cAMP levels. Stimulation of the receptor population via themuscarinic agonist iperoxo induced
a cellular DMR response at concentrations that are far lower than the corresponding concentration-
binding relationships (Schrage et al., 2013). The same authors reported this ampliﬁcation phenomenon
also for other ligands, including the natural ligand ACh. The exact nature of the ampliﬁcation pro-
cess is not understood so far, but may at least be partially attributed to intracellular signalling events
(Schrage et al., 2015). According to common literature we suppose regulators of G protein signalling
(RGS) and G protein-coupled receptor kinases (GRK) to be of relevance. These proteins are closely
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Fig. 1. Cartoon of the M2 receptor-dependent signalling and secondary messenger network in CHO-hM2 cells based on the known
literature. The receptor is activated by a ligand (e.g. iperoxo) and induces the membrane-bound signalling cascade including G
protein (G) activation and production of cAMP by adenylate cyclases (AC). Via cAMP the signal is transferred to the PKA-induced
phosporylation cascade. Detailed reactions are suppressed for simpliﬁcation. The detailed reaction system can be found in the
supplementary material.
related to the deactivation of the receptor and the GP subunits (De Vries et al., 2000; Pierce et al., 2002;
Hollinger et al., 2003. In this approach, we choose RGS14, GRK6 andGRK2 as important representatives
for each group.
Nowadays, several readouts for the stimulation response are well established, e.g. the Ca2+-level or
the cAMP concentration (Paredes et al., 2008; Hennen et al., 2013; Gabriel et al., 2003). In addition
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DMR has been introduced into the pharmaceutical ﬁeld in order to speciﬁcally quantify the stimulation
effect on the cytoskeleton (Fang et al., 2005; Schro¨der et al., 2011). The DMR is an optical biosensor
based procedure andmeasures the shift in wavelength resulting from intracellular mass movement caused
by rearrangement of cell organelles and transportation processes. The optical density is very sensitive
to intracellular reorganization and morphological changes of the cell, and by comparing the optical
density of unstimulated and stimulated cells one can measure the speciﬁc wavelength shift and draw
conclusions about the intensity of cellular response (Schro¨der et al., 2011). Maximal DMR response
induced by iperoxo occurs typically after approximately 10 minutes (Schrage et al., 2013). According to
the timescale and common literature, we did not consider transcriptional downstream responses (Shaywitz
& Greenberg, 1999; Mayr & Montminy, 2001).
In this work, we chose actin and tubulin as DMR markers. Actin and tubulin are closely related to
cellular movement and we assume a strong correlation between changes in both proteins and the relative
wavelength shift measured by DMR (Hammond et al., 2008; Schmidt & Hall, 1998). As described in
Fang et al. (2005); Strange (2009); Schro¨der et al. (2011) the wavelength shift is caused by intracellular
mass movement. Therefore, we took all proteins directly linked to actin and tubulin into account and
assumed their activation to be correlated with the wavelength shift (Fig. 1). For further references see the
supplementary material.
2.2 Mathematical modelling
All interactions shown in Fig. 1 are explicitly formalized as mass action based elementary reactions (Horn
and Jackson, 1972) and all known proteins and their occurring complexes are included. Hence biological
information from the available biochemical knowledge is preserved. Let x1, ..., xn denote concentrations
of all molecules in the system. Then the concentration change of molecule i can be written as
dxi
dt
=
m∑
j=1
sijvj, (2.1)
where sij is the stoichiometric coefﬁcient of molecule i in reaction j and vj denotes the corresponding rate
of reaction j. As an example, we here show the PKA activation by cAMP (Corbin et al., 1988)
PKA → PKA (2.2)
PKA + 2cAMP → PKA. (2.3)
Here, PKA denotes the inactive form of PKA. Let us denote the rate of both reactions by v1 and v2,
respectively. The stoichiometric coefﬁcients are s11 = s22 = −1, s12 = s21 = 1 and s32 = −2. We obtain
d[PKA]
dt
= s11v1 + s12v2 (2.4)
d[PKA]
dt
= s21v1 + s22v2 (2.5)
d[cAMP]
dt
= s32v2. (2.6)
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Altogether our modelled system contains 79 elementary reactions, which can be found in the supplemen-
tary material. The full reaction system can be represented via a stoichiometric matrix S ∈ Rn×m. In this
matrix, every molecule is represented by one row and every reaction is represented by one column.
There are some details that need to be mentioned: Our modelled system consists of several biochem-
ical reaction types, namely binding, stimulation and inhibition. These biochemical events need to be
represented appropriately in the reaction system and the stoichiometric matrix, respectively. This was
done as follows: Protein activation via phosphorylation was modelled with help of an intermediate mol-
ecule which represents the complex of the substrate and the related kinase. The kinase binds reversibly
to the substrate and forms an intermediate complex which then dissociates irreversibly into the kinase
and the modiﬁed substrate. For instance, GRK2 is phosphorylated by PKA (Cong et al., 2001). For this
purpose, we introduce the intermediate complex PKA : GRK2 and write the reaction system as
PKA + GRK2 PKA : GRK2 (2.7)
PKA : GRK2 → GRK2 + PKA. (2.8)
For every phosphorylation step, we assumed a backward reaction P∗ → P, which dephosphorylates the
phospho-proteinP∗ with the help of an unknown phosphatase. In our example, GRK2 is dephosphorylated
into GRK2
GRK2 → GRK2. (2.9)
Protein inhibition by kinases is modelled in a similar manner. A kinase binds reversibly to the target
protein and forms an intermediate complex which then dissociates irreversibly into the kinase and the
inactive protein. The inactive protein is now able to be activated again by another kinase. We illustrate
this process using the inhibition of GEF by GRK2 (Eijkelkamp et al., 2010)
GRK2 + GEF  GRK2 : GEF (2.10)
GRK2 : GEF → GRK2 + GEF. (2.11)
As shown above, these reactions can be represented in a stoichiometric matrix S. The dimension of
the stoichiometric matrix can be decreased by expressing the forward and backward direction of the
same reversible reaction by one row where reaction rates can be both positive and negative. This is in
contrast to strictly irreversible reactions where only positive reaction rates are allowed. We also used the
stoichiometric model to derive a system of ordinary differential equations based on the assumption of
mass action kinetics, see supplementary material.
2.3 Conservation relationships
Since signalling events are relatively fast we can assume that for each protein the overall total amount
of phosphorylated, bound and unphosphorylated proteins is approximately constant, provided that the
biological system is in steady state and themodel was correct. Hence, checking conservation relationships
is a means to check the consistency of our model.
According to Palsson (2006), conservation relationships under steady state conditions are mathemat-
ically identiﬁable from the null space of ST . That means conservation relationships are all those vectors
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g for which
STg = 0. (2.12)
Each entry in g corresponds to exactly one molecule. Analysis of the entries of vectors g provides thus
a means to verify whether the expected constant total concentration of each protein is fulﬁlled in reality.
Moreover, we can also obtain insights into possibly existing constant protein concentrations within whole
reaction cascades.
2.4 Stimulation of the system
We are interested in qualitative changes upon receptor stimulation. For the unstimulated system, we
assume a steady state characterized by constant concentrations of all molecules. Receptor stimulation
causes a perturbation of this steady state resulting in dynamic changes of molecular concentrations.
However, we assume that after some relaxation time the system will attain a supposingly different-
steady state, which is characterized by the molecular concentrations in the stimulated state. In reality,
the stimulated state does not need to be a dynamic equilibrium in the strict sense, but we believe it to be
a useful approximation for a situation of maximum response, where all concentrations are nearly con-
stant over time. We believe that this working hypothesis is useful to analyse qualitative changes between
the unstimulated and stimulated states, which is also supported by the fast—usually milliseconds—time
scale of the signalling events in comparison to the observable duration of responses to receptor stimulation.
Mathematically, all stationary reaction rates v in the steady state—so called ﬂuxes—are given as
solutions of the underdetermined system of equations
Sv = 0. (2.13)
The unstimulated and the stimulated state correspond to different solutions of this equation. Our strategy
will be to constrain the solution space of 2.13 using experimental data. We will then use Monte Carlo
Sampling (see below) to compare possible ﬂuxes in the simulated and unstimulated state.
For a qualitative comparison, we suppose the DMR response to be given as the sum of all ﬂuxes with
known inﬂuence on the wavelength shift
Response =
k∑
j=1
vj. (2.14)
Here, vi denotes the activating ﬂux related to molecule i with inﬂuence on the wavelength shift. The
sum runs over all k in-ﬂuxes into tubulin and actin, which are considered as markers of the DMR
response (Hammond et al., 2008; Schmidt & Hall, 1998; Schro¨der et al., 2011).
2.5 Sampling the ﬂux polytope
Since we are interested in the general behaviour of the system without incorporating additional rate
parameters, steady state solutions of the system can in principle be found through Markov Chain Monte
Carlo Hit-and-Run sampling (Smith, 1996; Brooks, 1998; Price et al., 2004). A single move in the Hit-
and-Run sampling is performed by making from a given feasible solution a uniform randomly chosen
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move within the unit sphere. Afterwards the step size is adjusted such that the new solution is also feasible
(Smith, 1996; Megchelenbrink et al., 2014). A solution v∗ is called feasible, if it satisﬁes
Sv∗ = 0 (2.15)
αi ≤ v∗i ≤ βi, ∀i = 1, ...,m (2.16)
with bounds αi,βi. Note, that without further constraints, ﬂuxes could take any real value, but in reality
ﬂuxes are bounded. Hence, we set for all reversible reactions αi = −1000 and βi = 1000 as loose
bounds. For irreversible reactions we set αi = 0. The ﬂux bounds can in principle be used to incorporate
experimental data. We will modify the ﬂux bounds to qualitatively incorporate fold changes between
stimulated and unstimulated cells, as explained in the following section.
2.6 Constrained ﬂux sampling
We incorporate partially available data of experimentally measured relative (steady state) molecular
concentrations into the above described ﬂux sampling scheme in order to make qualitative predictions
about ﬂux changes upon stimulation. The approach thus does not require detailed knowledge of kinetic
rate constants.
Let v˜j denote the steady state ﬂux of the j-th reaction in the case of an unstimulated receptor. According
to the law of mass action (see section 2.2) with rate parameters kj, we have
v˜j = kj
n∏
i=1
x˜
sij
i , (2.17)
where {x˜i} is the set ofmolecules taking part in the particular reaction and x˜i their concentrations. Note that
at this point we suppose involved reversible reactions to be split into two irreversible ones. Accordingly,
the ﬂux vˆj for the same reaction under stimulation can be deﬁned, now with concentrations xˆi. Usually,
in experiments relative concentration changes (fold changes) fi = xˆix˜i are determined. Obviously,
vˆj
v˜j
=
n∏
i=1
f siji (2.18)
which implies
vˆj = v˜j
n∏
i=1
f siji . (2.19)
Note that the stoichiometric coefﬁcients sij in most cases are 1. The equation suggests a principal two-step
procedure:
(1) Perform conventional ﬂux sampling for the unstimulated situation. This yields a set {v˜j}.
(2) Perform ﬂux sampling for the stimulated situation by plugging observed fold changes into Eq. (2.19)
in order to constrain sampled ﬂuxes.
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In reality it may be more appropriate to consider conﬁdence intervals [f Mini , f Maxi ] for fi because fold
changes are subject to uncertainty. This can be addressed straightforwardly by replacing Eq. (2.19) by an
inequality
v˜j
n∏
i=1
(f Mini )sij ≤ vˆj ≤ v˜j
n∏
i=1
(f Maxi )sij . (2.20)
The quantity v˜j in practice needs to be estimated from the empirical ﬂux distribution under steady state
conditions. A reasonable choice is to take the mean or median of the sample distribution plus/minus the
standard deviation for that purpose.
2.7 Elementary ﬂux modes
Schuster and Hilgetag introduced EFM analysis for characterizing the geometry of the solution polytope
of the equation system Sv = 0 in a biologically interpretable manner (Schuster & Hilgetag, 1994). All
solution vectors occur as linear combinations of EFMs. More speciﬁcally, Schuster & Hilgetag (1994)
and Llaneras & Pico (2010) consider the convex ﬂux polyhedral cone P(S)
P (S) =
{
v ∈ Rm
∣∣∣∣∣v =
ne∑
j=1
wjej wj ≥ 0
}
. (2.21)
EFMs are then deﬁned as the extreme rays or edges of the ﬂux cone P(S). A formal assumption made in
this equation is that reversible reactions are split into irreversible ones. Each EFM can be characterized as
the minimal set of reactions which are required for a sub-system to exist as a functional unit (Papin et al.,
2004). These sub-systems either reﬂect ﬂuxes through the whole reaction system or functional cycles
within the system. Thus, analysis of EFMs allows for identifying biologically functional and interpretable
‘building blocks’ of the biological reaction system. In case of signalling, this also implies that without
stimulation there exists no EFM representing the whole network and no EFM describing the signalling
ﬂow through it.
In this article,we combineEFManalysiswithCFS: after havingdetermined theﬂuxdistributions of the
overall system in stimulated and unstimulated conditions we map ﬂuxes to each of the calculated EFMs.
This is possible because each ﬂux corresponds uniquely to one reaction. We then compute the median
of all ﬂuxes related to a speciﬁc EFM. Since with our sampling procedure we generated a large (here:
100, 000) sample of ﬂux vectors we obtained an empirical distribution of these medians for each EFM.
The signiﬁcance of the difference in these distributions between stimulated and unstimulated conditions
can be assessed via a Wilcoxon rank test, yielding a P-value. Because we do not only compare one but
several EFMs, multiple testing correction of P-values is performed via control of the false discovery
rate (FDR) (Benjamini & Hochberg, 1995). Moreover, we estimated the median fold change between
stimulated and unstimulated conditions.
3. Results
3.1 Data: cAMP, PDE4 and DMR
Parts of the experimental data (dose-response relationships) were taken from Schrage et al. (2013): In that
article, DMR was measured at 13 different concentrations of the M2 receptor-speciﬁc activator iperoxo,
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(a) (b)
(c) (d)
Fig. 2. (a) DMR concentration-response curve of iperoxo modiﬁed from Schrage et al. (2013). The afﬁnity between iperoxo and
the receptor (pKD) of the iperoxo-induced ligand binding curve for intact cells (obtained from Schrage et al. (2014)) is marked by
the blue line. (b) Concentration effect curve of measured iperoxo-induced G protein alpha-s mediated cAMP accumulation with
standard deviations and estimated conﬁdence interval marked by the blue line. The inactivation of G protein alpha-i was induced
via a pretreatment with pertussis toxin (PTX). The inactivation of the cAMP inhibiting G protein alpha-i allows for matching the
measurements with their corresponding G protein alpha-s mediated network ﬂuxes. cAMP accumulation in the absence of test
compounds was set to 0% and maximum forskolin-induced binding was set to 100%. (c) Western Blot for the total amount of PDE4
(Pan-PDE4) and active PDE4 (pUCR1) under stimulation with 0.1μM iperoxo normalized against GAPDH. (d) Fold change for
normalized active PDE4 (pUCR1).
giving rise to dose-response curves (Fig. 2). In addition to these data by Schrage et al., cAMP response to
iperoxo treatment was measured here (Fig. 2). This was done after 30 minutes of iperoxo incubation with
a concentration of 0.1μM = 10−7M, which corresponds to a full DMR response (Schrage et al., 2013).
The induced cAMP fold change, calculated as the ratio between the cAMP level related to the iperoxo
concentration of 0.1μM and the 95% conﬁdence interval of the basal cAMP level (see Fig. 2) is given
by [2.22, 2.71].
In addition, we measured the activation of PDE4 after 30 minutes for the iperoxo concentration of
0.1μM. The 95% conﬁdence interval of active PDE4 level (see Fig. 2) is [3.21, 3.46]. For information
about the experimental details we refer the reader to the supplementary material.
3.2 Resulting conservation relationships
We uncovered 14 conservation relationships within the modelled biological system under steady state
conditions. Figure 3 illustrates which sets of proteins have to maintain a constant total concentration. As
illustrated in Fig. 3, we found at least one conservation relationship for each protein which reﬂects the
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Fig. 3. Calculated conservation relationships: each column represents one conservation relationship and each row a protein. Red
cells indicate proteins involved in a concentration relationship. The sum over all marked protein concentrations per column is
constant. The inactive form of each protein is indicated by the subscript ‘in’.
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(a) (b)
Fig. 4. Predicted ﬂuxes without stimulation (yellow/left) and under stimulation (green/right). (a) Boxplots illustrating the distri-
bution of selected ﬂuxes under different conditions using cAMP measurements. Yellow (left) boxes indicate the unstimulated and
green (right) boxes the stimulated condition. Ligand induced G protein activation is shown for the alpha-s subtype here. Boxplots
for all ﬂuxes can be found in the supplementary material. (b) Overall response given as the sum of ﬂuxes into tubulin and actin,
see 2.14. Related median fold changes are shown in Table 1.
Table 1 Median fold changes related to Fig. 4
GRK6 RGS14 cAMP PKA cAMP Response
Regulation Regulation Production Activation Degradation
fold change (median) 1.27 1.33 1.47 1.54 1.68 1.36
main endogenous signalling cycles. Thus our expectations coming from the signalling character of our
modelled system are veriﬁed.
3.3 Constraint ﬂux sampling correctly predicts DMR response under receptor activation
We applied the CFS framework described above incorporating cAMP as well as PDE4 fold changes into
ﬂux constraints. DMR response measurements were not taken into consideration at this point, but left out
for independent validation. Figure 4 depicts the distributions of those selected ﬂuxes, which according
to our CFS analysis are predicted to show a statistically signiﬁcant shift under stimulation (FDR <1%,
Wilcoxon signed rank test with Benjamini and Hochberg’s FDR control of P-values for multiple testing
(Hollander, 1999; Benjamini & Hochberg, 1995)).
CFS predicts a signiﬁcant change of RGS 14. A slight decrease of the receptor de-activation and
increase of the GP subtype alpha-i de-activation via RGS14 can be expected under stimulation according
to our simulation. The receptor de-activation is compensated by an increasing receptor recycling. This
phenomenon of signal regulation by RGS14 and GRK6 is well described in the literature where both
proteins are known as important signal regulators (Pierce et al., 2002;Dale&Rang, 2011;Berridge, 2014).
The RGS family is involved into the extinction of GP-dependent signalling (Zhang andMende, 2011), e.g.
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Table 2 Proteins ranked with respect to their predicted inﬂuence on the DMR
response. The inﬂuence on the response was estimated by the median fold change
expected by a knock-out simulation of each protein. The statistical signiﬁcance
of each simulated fold change is shown in terms of FDR. A high fold change
implies a strong inﬂuence of the particular protein
Rank FDR Median fold change Median ﬂux difference Protein
(simulated) (simulated)
1 < 1E − 6 1.24 680 GP alpha-o
2 < 1E − 6 1.24 675 RGS14
3 < 1E − 6 1.18 545 PDE4
4 < 1E − 6 1.17 535 GRK2
5 < 1E − 4 1.12 395 GP alpha-i
6 < 1E − 4 1.12 394 GRK6
via receptor desensitization or endocytosis (Reiter & Lefkowitz, 2006). This causes the downregulation
of GP alpha-i downstream and together with cAMP forms a positive feedback loop. More speciﬁcally,
the inhibition of the cAMP inhibitor GP alpha-i subunit leads to an increase of the cAMP production. In
addition, signiﬁcant GP alpha-i de-activation causes a signiﬁcant increase of GRK6 activation.
The boxplots clearly highlight that—besides cAMP—under stimulation increasing levels of AMP
production and cAMP degradation are expected, which is in agreement with current literature (Pierce
et al., 2002; Sunahara & Taussig, 2002; Strange, 2009; Berridge, 2014). CFS is able to correctly predict a
signiﬁcant positivewavelength shift, i.e. DMR response, under receptor stimulationwhich is in agreement
with our experimental validation data (see Fig. 2). Hence, CFS allows for a qualitative check of our
pathway model.
3.4 Knock-out simulations
To further check the hypothesized relevance of RGS14 for the observed DMR response we conducted
an in silico knock-out simulation. This means we restricted all ﬂuxes going through this molecule to
zero while repeating our CFS. To investigate the effect of the different molecules on the DMR response,
we performed knock-out simulations for all molecules except for GP alpha-s, AMP, AC, cAMP, PKA,
the receptor and the ligand. We then ranked the molecules according to their statistical signiﬁcance of
the inﬂuence on DMR related ﬂuxes. GP alpha-s is not considered for the knock-out simulation because
no steady state solutions are possible when constraining the ﬂuxes through these important signalling
molecules to zero. AMP, AC, cAMP, PKA, the receptor and the ligand are not considered because these
are characteristic molecules for signalling and removing these molecules is unphysiological. Table 2
shows the proteins with inﬂuence on the response under stimulation.
Altogether our simulations underline our ﬁndings from section 3.3. The highest impact was found
for RGS14 and GP alpha-o, followed by PDE4. Furthermore, GRK6 has a signiﬁcant inﬂuence.
3.5 Combining EFMs and CFS reveals important sub-networks and regulatory mechanisms
In a last step, we applied EFM analysis to the system with ligand stimulation (see section 2.4), resulting
in 63 EFMs (see supplementary material). Notably, many of these EFMs represent similar biological
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Table 3 Signiﬁcant EFMs (FDR < 1E − 6) ranked by their
median predicted fold change induced by stimulation. Note that
the ﬁrst three fold changes are not computable, because without
stimulation there is no ﬂux through these EFMs. For the complete
table please see supplementary material
Rank Fold change Median ﬂux Median ﬂux Related to
(unstimulated) (stimulated)
1 NA 0 619 GRK6
2 NA 0 539 GRK6:R
3 NA 0 499 Receptor
4 2.00 250 501 GP alpha-s
5 1.68 499 837 PDE
6 1.58 506 816 GEF
7 1.57 507 815 GEF
8 1.57 507 816 GEF
9 1.57 507 815 GEF
10 1.54 446 682 cAMP
11 1.54 446 682 cAMP
12 1.54 446 682 cAMP
13 1.54 446 682 GEF
14 1.53 513 789 GEF
15 1.52 513 789 GEF
16 1.52 514 788 GEF
17 1.52 514 788 cAMP
18 1.48 481 709 cAMP
19 1.48 481 709 cAMP
20 1.48 481 709 cAMP
21 1.48 481 709 cAMP
22 1.34 500 709 RGS14
23 1.34 500 709 RGS14
24 1.33 500 707 RGS14
25 1.33 500 707 RGS14
26 1.27 500 379 GRK6
mechanisms. We ranked all EFMs with respect to their predicted change under stimulation by the method
described in section 2.7. Table 3 shows all EFMs with an FDR lower than 0.001 and a median fold change
greater than 1. Interestingly enough, four of the most signiﬁcant EFMs describe the GP alpha regulation
via RGS14, and also the receptor regulation via GRK6 is among the most signiﬁcant EFMs (Figs 5 and 6).
This is in full agreement with our previous ﬁndings and provides a possible explanation for the relevance
of these molecules. Further signiﬁcant EFMs are related to PDE activation and cAMP/GEF production
(in agreement with our experimental data).
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Fig. 5. Elementary ﬂux mode for G protein (G) regulation via RGS14. First the inactive G protein complex consisting of the
subunits alpha-i and beta/gamma binds to the active receptor and the bound GDP (Guanosine diphosphate) is replaced by GTP
(Guanosine-5’-triphosphate) while the G protein dissociates from the receptor and splits into its subunits beta/gamma and alpha-
i. Afterwards the activated alpha subunit is deactivated by replacing GTP with GDP-mediated by RGS14. In the last step, the
deactivated GDP-bound alpha-subunit again associates with the beta/gamma subunit and forms the inactive G protein.
Fig. 6. Elementary ﬂux mode for the GRK-mediated receptor inactivation via phosphorylation. The ligand-bound receptor gets
phosphorylated by GRK. The phosporylated and hence inactive receptor is no longer able to mediate G protein activation. After
ligand-dissociation the receptor gets de-phosphorylated and is now again able to mediate G protein activation.
4. Discussion
In this article, we presented a comprehensive mathematical model of the M2 receptor-dependent joint
signalling and secondary messenger network. The motivation for our work comes from the pharmacolog-
ical relevance of the M2 receptor and the induced cellular responses. Whereas in principle the individual
parts of our studied system are well described in the biological literature, to our knowledge there have
been no attempts so far to combine these information into a mathematical model.
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A quite speciﬁc property of our model is the combination of pure signalling events on protein level
with secondary messenger molecule production and degradation. Following Behre & Schuster (2009),
we here adapted methods from stoichiometric matrix analysis (EFM analysis, conservation laws, ﬂux
sampling) that are usually known in the ﬁeld ofmetabolic network analysis and do not require information
about kinetic rate constants. Thesemethods operatemainly on the level of a biochemical reaction network.
We demonstrated that in this way it is possible to draw biologically meaningful conclusions about the
principle behaviour of our studied system, which are in agreement with the current knowledge. In that
context, our proposed CFS method allowed to include measured cAMP and PDE fold changes in order to
make qualitative predictions about receptor stimulation effects on network level that were veriﬁable via
experimental data (DMR measurement) not been used by CFS. We demonstrated that our CFS method
can be used in the context of in silico knock-out simulations in order to identify relevant features of our
studied system. More speciﬁcally, we found RGS14 of major relevance, which is in agreement with the
current literature, but certainly requires further experimental investigations of the biological system under
consideration. Thanks to our combination of CFS and EFM analysis we think that this is speciﬁcally due
to the GP alpha-i regulation via RGS14.
Altogether we think that CFS, as well as other established methods for stoichiometric matrix analysis,
could be valuable tools for model checking for mixed signalling and non-signalling networks. Such a
model checking procedure would also simplify and speed up possible follow upmodel reﬁnements driven
by quantitative time series measurements.
Supplementary material
Supplementary material is available at http://imammb.oxfordjournals.org.
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